Comparative assessment of “plaque/media” change on three modalities of IVUS immediately after implantation of either everolimus-eluting bioresorbable vascular scaffold or everolimus-eluting metallic stent in Absorb II study

[1]  P. Serruys,et al.  Hybrid intravascular imaging: recent advances, technical considerations, and current applications in the study of plaque pathophysiology , 2017, European heart journal.

[2]  Patrick W. Serruys,et al.  Efecto del armazón bioabsorbible liberador de everolimus en la aterosclerosis coronaria , 2016 .

[3]  J. Reiber,et al.  Impact of the Everolimus-eluting Bioresorbable Scaffold in Coronary Atherosclerosis. , 2016, Revista espanola de cardiologia.

[4]  P. Serruys,et al.  Reproducibility of intravascular ultrasound radiofrequency data analysis (virtual histology) with a 45-MHz rotational imaging catheter in ex vivo human coronary arteries. , 2015, Journal of cardiology.

[5]  J. Reiber,et al.  Echogenicity as a surrogate for bioresorbable everolimus-eluting scaffold degradation: analysis at 1-, 3-, 6-, 12- 18, 24-, 30-, 36- and 42-month follow-up in a porcine model , 2015, The International Journal of Cardiovascular Imaging.

[6]  P. Serruys,et al.  A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial , 2015, The Lancet.

[7]  R. Whitbourn,et al.  Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[8]  Akiko Maehara,et al.  Clinical and angiographic characteristics of patients likely to have vulnerable plaques: analysis from the PROSPECT study. , 2013, JACC. Cardiovascular imaging.

[9]  P. Serruys,et al.  ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease c , 2012, American heart journal.

[10]  Bernard Chevalier,et al.  First Serial Assessment at 6 Months and 2 Years of the Second Generation of Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold: A Multi-Imaging Modality Study , 2012, Circulation. Cardiovascular interventions.

[11]  Susan Veldhof,et al.  Natural history of coronary atherosclerosis by multislice computed tomography. , 2012, JACC. Cardiovascular imaging.

[12]  Peter Libby,et al.  Effect of two intensive statin regimens on progression of coronary disease. , 2011, The New England journal of medicine.

[13]  P. Serruys,et al.  Assessment of coronary atherosclerosis progression and regression at bifurcations using combined IVUS and OCT. , 2011, JACC. Cardiovascular imaging.

[14]  P. Serruys,et al.  Clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound regression/progression studies. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[15]  P. Serruys,et al.  Quantitative multi-modality imaging analysis of a fully bioresorbable stent: a head-to-head comparison between QCA, IVUS and OCT , 2011, The International Journal of Cardiovascular Imaging.

[16]  Bernard Chevalier,et al.  Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes. , 2011, Journal of the American College of Cardiology.

[17]  R. Whitbourn,et al.  Temporal changes of coronary artery plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold , 2011, The International Journal of Cardiovascular Imaging.

[18]  Bernard Chevalier,et al.  Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery Stenosis: Six-Month Clinical and Imaging Outcomes , 2010, Circulation.

[19]  Patrick W Serruys,et al.  Tissue characterisation using intravascular radiofrequency data analysis: recommendations for acquisition, analysis, interpretation and reporting. , 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[20]  P. Serruys,et al.  Assessment of the absorption process following bioabsorbable everolimus-eluting stent implantation: temporal changes in strain values and tissue composition using intravascular ultrasound radiofrequency data analysis. A substudy of the ABSORB clinical trial. , 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[21]  Paul Schoenhagen,et al.  Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. , 2003, JAMA.

[22]  M Schartl,et al.  Use of Intravascular Ultrasound to Compare Effects of Different Strategies of Lipid-Lowering Therapy on Plaque Volume and Composition in Patients With Coronary Artery Disease , 2001, Circulation.

[23]  C. Tracy,et al.  American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. , 2001, Journal of the American College of Cardiology.

[24]  P. Dhawale,et al.  Intracoronary ultrasound-defined plaque composition: computer-aided plaque characterization and correlation with histologic samples obtained during directional coronary atherectomy. , 1995, American heart journal.

[25]  J. Edelstein,et al.  Ultrasonic-pathological comparison of the human arterial wall. Verification of intima-media thickness. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.